210 related articles for article (PubMed ID: 31593523)
41. Study protocol: assessing the association between corporate financial influence and implementation of policies to tackle commercial determinants of non-communicable diseases: a cross-sectional analysis of 172 countries.
Allen LN; Wigley S; Holmer H
BMJ Open; 2022 Aug; 12(8):e055656. PubMed ID: 36041766
[TBL] [Abstract][Full Text] [Related]
42. Industry funding of patient and health consumer organisations: systematic review with meta-analysis.
Fabbri A; Parker L; Colombo C; Mosconi P; Barbara G; Frattaruolo MP; Lau E; Kroeger CM; Lunny C; Salzwedel DM; Mintzes B
BMJ; 2020 Jan; 368():l6925. PubMed ID: 31969320
[TBL] [Abstract][Full Text] [Related]
43. U.S. research universities' institutional conflict of interest policies.
Slaughter S; Feldman MP; Thomas SL
J Empir Res Hum Res Ethics; 2009 Sep; 4(3):3-20. PubMed ID: 19754230
[TBL] [Abstract][Full Text] [Related]
44. Strengthening conflict-of-interest policies in medicine.
Cosgrove L; Bursztajn HJ
J Eval Clin Pract; 2010 Feb; 16(1):21-4. PubMed ID: 19874437
[TBL] [Abstract][Full Text] [Related]
45. What do we really know about conflicts of interest in biomedical research?
Warner TD; Gluck JP
Psychopharmacology (Berl); 2003 Dec; 171(1):36-46. PubMed ID: 14624332
[TBL] [Abstract][Full Text] [Related]
46. Assessment by human research ethics committees of potential conflicts of interest arising from pharmaceutical sponsorship of clinical research.
Newcombe JP; Kerridge IH
Intern Med J; 2007 Jan; 37(1):12-7. PubMed ID: 17199839
[TBL] [Abstract][Full Text] [Related]
47. Disclosing conflicts of interest to research subjects: an ethical and legal analysis.
Resnik DB
Account Res; 2004; 11(2):141-59. PubMed ID: 15675055
[TBL] [Abstract][Full Text] [Related]
48. Institutional Conflict of Interest Policies at U.S. Academic Research Institutions.
Resnik DB; Ariansen JL; Jamal J; Kissling GE
Acad Med; 2016 Feb; 91(2):242-6. PubMed ID: 26535868
[TBL] [Abstract][Full Text] [Related]
49. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Eur Heart J; 2012 Mar; 33(5):587-94. PubMed ID: 22383145
[TBL] [Abstract][Full Text] [Related]
50. Conflicts of interest: conceptual and normative issues.
Pritchard MS
Acad Med; 1996 Dec; 71(12):1305-13. PubMed ID: 9114888
[TBL] [Abstract][Full Text] [Related]
51. Society for Maternal-Fetal Medicine Special Statement: Society for Maternal-Fetal Medicine's conflict of interest policy.
; Waters T; McNulty J; Wylie B; Sciscione A; Iriye B
Am J Obstet Gynecol; 2020 Dec; 223(6):B47-B57.e3. PubMed ID: 32971012
[TBL] [Abstract][Full Text] [Related]
52. Conflict of interest policies for organizations producing a large number of clinical practice guidelines.
Norris SL; Holmer HK; Burda BU; Ogden LA; Fu R
PLoS One; 2012; 7(5):e37413. PubMed ID: 22629391
[TBL] [Abstract][Full Text] [Related]
53. Innovation incentives or corrupt conflicts of interest? Moving beyond Jekyll and Hyde in regulating biomedical academic-industry relationships.
Taylor PL
Yale J Health Policy Law Ethics; 2013; 13(1):135-97. PubMed ID: 23815042
[TBL] [Abstract][Full Text] [Related]
54. 'Public enemy no. 1': Tobacco industry funding for the AIDS response.
Smith J; Thompson S; Lee K
SAHARA J; 2016; 13(1):41-52. PubMed ID: 27023371
[TBL] [Abstract][Full Text] [Related]
55. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Rev Port Cardiol; 2012 Apr; 31(4):329-36. PubMed ID: 22863109
[TBL] [Abstract][Full Text] [Related]
56. Food industry donations to patient advocacy organisations focussed on non-communicable diseases.
Del Giudice IM; Tsai KA; Arshonsky J; Bond S; Bragg MA
Public Health Nutr; 2022 Oct; 26(3):1-9. PubMed ID: 36305342
[TBL] [Abstract][Full Text] [Related]
57. Financial conflict-of-interest policies in clinical research: issues for clinical investigators.
Boyd EA; Cho MK; Bero LA
Acad Med; 2003 Aug; 78(8):769-74. PubMed ID: 12915362
[TBL] [Abstract][Full Text] [Related]
58. Confronting conflict: addressing institutional conflicts of interest in academic medical centers.
Liang BA; Mackey T
Am J Law Med; 2010; 36(1):136-87. PubMed ID: 20481404
[TBL] [Abstract][Full Text] [Related]
59. Conflict of interest in public health: should there be a law to prevent it?
Gupta A; Holla R; Suri S
Indian J Med Ethics; 2015; 12(3):172-7. PubMed ID: 26060144
[TBL] [Abstract][Full Text] [Related]
60. Intrinsic conflicts of interest in clinical research: a need for disclosure.
Sollitto S; Hoffman S; Mehlman M; Lederman RJ; Youngner SJ; Lederman MM
Kennedy Inst Ethics J; 2003 Jun; 13(2):83-91. PubMed ID: 14569995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]